<DOC>
	<DOCNO>NCT00662883</DOCNO>
	<brief_summary>To assess effect nasal corticosteroid treatment rate extent intranasal absorption PMI-150 ( intranasal ketamine HCl )</brief_summary>
	<brief_title>Assessing Effects Nasal Corticosteroid PMI-150 ( Intranasal Ketamine )</brief_title>
	<detailed_description>Subjects participate two-period , single-sequence study ass effect administration nasal corticosteroid , Nasonex ( mometasone furoate ) , pharmacokinetics , safety tolerability PMI-150 ( intranasal ketamine HCl ) healthy adult volunteer .</detailed_description>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>healthy adult nonsmoker drug use nasal abnormality airway abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>ketamine</keyword>
	<keyword>corticosteroid</keyword>
	<keyword>intranasal</keyword>
	<keyword>phase I</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>